Conferences & Events > Israeli Conference > Israeli Agenda
 
 

Agenda

Day 1: Tuesday, November 19, 2019

8:50 - 9:00 AM
Opening Remarks
9:00 - 9:20 AM
The medical challenge at the chemical terror scene
Yuval Cohen, MD, CBRN Branch, Israel Defense Forces, Israel
9:20 - 9:40 AM
Treatment of acute cyanide poisoning: time to move forward
Yuval Cohen, MD, CBRN Branch, Israel Defense Forces, Israel
9:40 - 10:00 AM
Preparation of general hospitals in Israel to mass toxicological event  - from doctrine to drills
Ophir Lavon, MD, Carmel Medical Center, Israel
10:00 - 10:20 AM
Preparation of general hospitals in Israel to mass toxicological event  - from doctrine to drills
Eran Alon, MD, Home Front Command, Israel Defense Forces, Israel
10:20 - 10:40 AM
Break
10:40 - 10:55 AM
Eye pathology, respiratory toxicity and death following whole body VX vapor exposure are prevented only by repetitive antidotal treatment
Eugenia Bloch-Shilderman, PhD, Israel Institute for Biological Research, Israel
10:55 - 11:20 PM
Fourth generation nerve agents
Charles Mckay, MD, Hartford Hospital, CT, USA
11:20 - 11:45 PM
Myths and misinformation about casual dermal exposure to fentanyl among first responders
Lewis Nelson, MD, Rutgers Medical Center, NJ, USA
11:45 - 12:10 PM
Weaponized opioids
Nicholas Connors, MD, Medical University of South Carolina, SC, USA
12:10 - 1:10 PM Lunch
1:10 - 1:25 PM
Adherence with prescription drugs in pregnant and breastfeeding women consulting with the Israel Poison Information Center Teratology Service
Yael Lurie, MD, Rambam Health Care Campus, Israel
1:25 - 1:40 PM
Vancomycin - evolution of guidelines and clinical practice
Laila Nasar, PharmD, Rambam Health Care Campus, Israel
1:40 - 2:00 PM
Dipyrone: an update
Matti Berkovitch, MD, Shamir Medical Center, Israel
2:00 - 2:15 PM
Data sources supporting Food and Drug Administration drug safety communications
Daniel Shepshelovich, MD, Rabin Medical Center, Beilinson Campus, Israel
2:15 - 2:35 PM  Break
 2:35 - 2:55 PM
Drug induced liver injury: state of the art
Javier Waksman, MD, FibroGen, Inc., USA
 2:55 - 3:15 PM
Novel buprenorphine formulations and administration methods for opioid agonist therapy
Stephanie Weiss, MD, PhD, Wake Forest Baptist Medical Center, NC, USA
 3:15 - 3:30 PM
The interaction between direct oral anti coagulants (DOACs) and antiepileptic drugs: implications on clinical outcomes and DOACs levels. What do we know?
Mordechai Muszkat, MD, Hadassah Medical Center, Mt. Scopus, Jerusalem, Israel
 3:30 - 3:50 PM
Herbal-induced liver injury: clinical and immunogenetic causality assessment 
Manuela Neuman, PhD, University of Toronto, Canada
 

Day 2: Wednesday, November 20, 2019

8:50 - 9:00 AM
Announcements / Housekeeping
9:00 - 9:15 AM
Thrombotic microangiopathy and acute renal failure following Echis coloratus bite in Israel
Yael Lurie, MD, Rambam Health Care Campus, Israel
9:15 - 9:30 AM
Arum Palaestinum poisoning - revenge of the witch
Aus Maree, Hadassah Medical Center, Mt. Scopus, Jerusalem, Israel
9:30 - 9:45 AM
Environmental exposures of firefighters in Israel
Elkana Kohn, MD, Shamir Medical Center, Israel
9:45 - 10:00 AM
Environmental tobacco smoke exposure among children with and without respiratory symptoms: A case-control study
Ayala Grinshpun, MD, Shamir Medical Center, Israel
10:00 - 10:15 AM
Adherence of care givers of children to advice provided by a national poison information center
Gal Neuman, MD, Rambam Health Care Campus, Israel
10:15 - 10:30 AM
Impact of a toxicolgy consultation service in a large tertiary care teaching hospital
Miguel Glatstein, MD, Sourasky Medical Center, Israel
10:30 - 10:50 AM Break
10:50 - 11:05 AM
A bloody mess: brodifacoum and K2
Michael Mullins, MD, Washington University School of Medicine, St. Louis, MO, USA
11:05 - 11:20 AM
Trends of Intentional Drug Overdose Among Youth: A Population-based Cohort Study
Yaron Finkelstein, MD, Hospital for Sick Children, Toronto, ON, Canada
11:20 - 11:35 AM
The increasing rate of suicide attempts by self-poisoning in the US among youth and adolescents with a focus on diphenhydramine- another emerging public health concern
Erica Liebelt, MD, University of Washington School of Medicine, Seattle, WA, USA
11:35 - 11:50 AM
Abuse of nonscheduled medications and nonprescription drugs
Wendy Klein-Schwartz, PharmD, University of Maryland School of Pharmacy, MD, USA
11:50 - 12:10 PM
Cannabis toxicology in adolescents- the new reality
Gideon Koren, MD, Ariel University, Israel
12:10 - 1:10 PM Lunch
1:10 - 1:25 PM
Fatalities in poisoned patients managed by medical toxicologists
Nir Friedman, MD, The Toxicology Investigators Consortium; Safra Children's Hospital - Sheba Medical Center, Israel
1:25 - 1:40 PM
Quality Performance Measures in Medical Toxicology
Paul Wax, MD, University of Texas Southwestern, Dallas, TX, USA
 1:40 - 1:55 PM
Poison center consultations and legal liability
Ophir Lavon, MD, Carmel Medical Center, Israel
 1:55 - 2:10 PM
Lack of predictive value of provoked urine test results in the determination of toxic exposures
Jeffrey Brent, MD, University of Colorado, School of Medicine, CO, USA
 2:10 - 2:25 PM
Toxicity assessment of disposable medical devices
David Stepensky, PhD, Ben-Gurion University of the Negev, Israel
 2:25 - 2:45 PM Break
2:45 - 3:00 PM
Hyperbaric oxygen (HBO) therapy for toxicologists: under pressure
Peter Akpunonu, MD, University of Kentucky, KY, USA
3:00 - 3:15 PM 
A quick trip through the QT nomogram
Michael Mullins, MD, Washington University School of Medicine, St. Louis, MO, USA
3:15 - 3:30 PM  
Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case-control Study
Yaron Finkelstein, MD, Hospital for Sick Children, Toronto, ON, Canada 
3:30 - 3:45 PM   
Conducting Multicenter Medical Toxicology Research Network through the Toxicology Investigators Consortium
Paul Wax, MD, University of Texas Southwestern, Dallas, TX, USA 
 3:45 - 4:00 PM  
The effects of a 30-minute water-pipe smoking session on cognitive measures on cardio-pulmonary parameters
Yedida Bentur, MD, Rambam Health Care Campus, Israel